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1. Introduction
We all are exposed through air, food, drinks and skin contacts to harmful compounds
throughout the period of our lifetime, including, a variety of pharmaceuticals and food-de‐
rived carcinogen metabolite (e.g. N-acetoxy-PhIP), [52], plant toxins (such as glycoalkaloids in
nightshades1, cyanogenic glucosides 2, or pyrrolizidine alkaloids in some herbs and herbal teas),
xenobiotics3 producing during early human pregnancy, fungal and bacterial toxins such as
aflatoxins4; and cyanotoxin5; as well as free radicals and hydroperoxides. Many of these
compounds are lipophilic and the organism can get rid of them only through metabolism.
Biotransformation has been conveniently categorized into three distinct phases, which act in
a tightly integrated manner. Phases I and II enzymes catalyze the conversion of a lipophilic,
non-polar xenobiotic into a more water-soluble and therefore less toxic metabolite, which
can then be more easily excreted from the body. Phase I biotransformation seems to be en‐
zymes that catalyzes oxidation, reduction or hydrolyze reactions, it usually converts sub‐
strates to more polar forms by introducing or unmasking a functional group (e.g., —OH, —
NH2, or —SH). Phase I consist primarily of microsomal enzymes, which are found abun‐
dantly in the liver, gastrointestinal tract, lung and kidney, consisting of families and subfa‐
milies of enzymes that are classified based on their amino acid sequence identities or
similarities. [84]. Many of the enzymes like monooxygenases are found in the endoplasmic
1 - Plants like potatoes, tomatoes, peppers, egg plant, tobacco, some spices.
2- Like bitter almond, cassava root, sorghum root, lima bean, fruit seed, etc.
3 - Chemical compounds foreign to the human organism without nutritional value
4 - A group of mycotoxins of which aflatoxin B1 is the most potent hepatocarcinogen
5 - A toxin producing by cyanobacteria of which microcystin-LR is predominant
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reticulum membrane, but others such as the dehydrogenases for example alcohol dehydro‐
genases and peroxidases located in the cytoplasm, while still others such as monoamine oxi‐
dase are localized in mitochondria. Monooxygenases are also known as mixed function
oxidases because in a typical reaction, one molecule of oxygen is consumed (reduced) per
substrate molecule: one oxygen atom appearing in the product and the other in a molecule
of water. The reaction scope of monooxygenases includes heteroatom oxidation, aromatic
and aliphatic hydroxylation, epoxidation, and Baeyer-Villiger oxidation. There are two ma‐
jor types of microsomal monooxygenase, both of which require NADPH as an external re‐
ductant: the cytochrome P450 (CYP) system and flavin-containing monooxygenases. The
mechanism of CYP is a complex cascade of individual steps involving the interaction of pro‐
tein redox partners and consumption of reducing equivalents, usually in the form of
NADPH. The iron heme containing enzyme, CYP, consists of two enzymes: NADPH–cyto‐
chrome P450 reductase and CYP. It is involved in the oxidative metabolism of many endog‐
enous substances such as steroids and bile acids, as well as the detoxication of a wide
variety of xenobiotics. It can oxidize AFB1 to several products. Only one of these, the 8,9-
exo-epoxide, appears to be mutagenic and the others are detoxification products. P4503A4,
which can both activate and detoxicate AFB1, is found in the liver and the small intestine.
[33], [52]. Flavincontaining monooxygenases catalyze an NADPH- and an oxygen-requiring
oxidation of substances (primarily xenobiotics) bearing functional groups containing nitro‐
gen, sulfur, or phosphorus. The properties of the CYPs electron transport systems have also
been reported [77].
In detoxification pathway, a series of enzyme-catalyzed processes with broad specificities
convert the toxic substances into less toxic metabolites by chemical reactions within the
body. Although biotransformation reactions take place within cytoplasm and mitochondria
but they mostly happen within endoplasmic reticulum (E.R). Cell types also differ in their
biotransforming potential for example cells located near the major points of xenobiotic entry
into the body such as liver, lung, and intestine possess greater concentrations of biotrans‐
forming enzymes than others [52].
Phase II conjugation reactions which generally act follow phase I activation consists of reac‐
tions in which metabolites containing appropriate functional groups are conjugated with
substances such as glucuronate, glutamate, sulfate, reduced glutathione or uridine diphos‐
phate (UDP)-glucuronic acid to finally discharge them through urine or bile. In general, con‐
jugation dramatically improves solubility, which then promotes rapid excretion. Among the
several types of conjugation reactions which are present in the body, including glucuronida‐
tion, sulfation, and glutathione and amino acid conjugation, glutathione which is catalyzed
by glutathione S-transferases, is the major phase II reaction in many species [52]. With the
exception of acetylation, methylation and fatty acid conjugation, the strategy of phase II bio‐
transformation is to convert a xenobiotic to a more hydrophilic form via the attachment of a
chemical moiety which is ionizable at physiological pH. This metabolic transformation also
results in reduced affinity of the compound for its cellular target. [67], [23].
In animals, elimination of the soluble compounds from cells and excretion of biotrans‐
formed molecules from the body referred to as phase III. It has been suggested that the
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phase III of detoxification system to be called antiporter activity. Antiporter activity is an
important factor in the first pass metabolism of pharmaceuticals and other xenobiotics. The
antiporter is an energy-dependent efflux pump, which pumps xenobiotics out of a cell,
thereby decreasing the intracellular concentration of xenobiotics. In eukaryotic organisms,
they are actively excreted or compartmentalized in the vacuole by ATP-dependent GS-X
pumps [42], [27]. Indeed, as the glutathionylated moiety is hydrophilic, the conjugate cannot
usually simply re-diffuse back into the cell [77]. Antiporter activity in the intestine appears
to be co-regulated with intestinal phase I CYP3A4 enzyme. This observation suggests the
antiporter may support and promote detoxification. Possibly, its function of pumping non-
metabolized xenobiotics out of the cell and back into the intestinal lumen, may allow more
opportunities for phase I activity to metabolize the xenobiotic before it is taken into circula‐
tion. Although, most literature on detoxification refers to liver enzymes, as the liver is the
site of the majority of detoxification activity for both endogenous and exogenous com‐
pounds, however, the first contact the body with the majority of xenobiotics take places in
the gastrointestinal tract. Intestinal mucosa possesses enzyme systems capable of various
types of biotransformation of xenobiotics [52]. Among the detoxification pathways, gluta‐
thione conjugation pathway is the prominent route of AFB1 inactivation in liver of mamma‐
lians. Depending on the availability of cellular GSH and the activation of glutathione S-
transferase subclasses, detoxification of AFB1 is facilitated [24].
2. Glutathione
Glutathione is a ubiquitous thiol-containing isotripeptide (γ-glu-cys-gly, FW 307.3), consist‐
ing of glycine, glutamic acid and cysteine molecules which was first discovered by Sir Fre‐
drick Gowland Hopkins in 1920s, synthesized de novo in mammalian cells (Figure 1). This
water soluble antioxidant compound is an unusual peptide in that the peptide bond be‐
tween the glutamate residue and the cysteine residue is formed with the γ-carboxylate
group of the former rather than the α-carboxylate group. Today along with β-carotene, as‐
corbic acid (vitamin C), α-tocopherol (vitamin E) and flavonoids etc., GSH6 is commonly re‐
ferred to as an antioxidant [17], which neutralizes free radicals due to the high electron-
donating capacity of its sulfydryl (-SH) group, [13], and prevents damage to important
cellular components, implicates in the cellular defense against xenobiotics. Glutathione sta‐
tus is a highly sensitive indicator of cell functionality and viability. Its levels in human tis‐
sues normally range from 0.1 to 10 mM, being most focused in liver (up to 10 mM) and in
the spleen, kidney, lens, erythrocytes and leukocytes and its emptying be joined to a variety
of diseases. Under normal conditions, glutathione is predominantly present in its reduced
form, with only a small proportion present in its fully oxidized state [20].
Moreover, the GSH/GSSG7 pair with their high reduction potential participates in maintaining
other cellular thiol in a reduced state. Finally, GSH tends to a substrate or cofactor in some of
6 - Glutathione, reduced form
7 - Glutathione, oxidized state
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GSH linked enzymes. There are a number of GSH linked enzymes that are involved in cellular
protection against toxic substances. The glyoxalase I and II which are responsible for catalyz‐
ing the conversion of methylglyoxal (a by-product in glycolysis) to lactic acid are among these
enzymes [76].  Glutathione reductase  (GR)  which catalyzes  the  reduction of  GSSG using
NADPH as a reductant is also a glutathione-linked enzyme involved in cell protection. GR is
important to keep the high cellular reductive potential. Selenium dependent glutathione perox‐
idase are other GSH-linked enzymes that catalyze the reduction of peroxides using GSH as the
reducing agent [7]. Finally, last but not the least, glutathione transferases are also GSH depend‐
ent enzymes with many properties among which catalyzing the conjugation of GSH to vari‐
ous electrophilic compounds is one of the most investigated function [25].
Figure 1. Structure of reduced glutathione; glutamate is linked in an isopeptide bond (via its γ-carboxyl group) to cys‐
teine, which in turn forms a peptide linkage with glycine
3. Glutathione S-transferase
Glutathione S-transferases (GST, EC 2.5.1.18), which first discovered as enzymes in 1961
[12], are abundant proteins encoded by a highly divergent, ancient gene family. These major
cellular detoxification enzymes present mostly in liver and kidney as well as intestine. In
spite of 40 years of research the exact function of this protein is more complex than ever, but
it has been found that these intracellular dimeric proteins, play a major role in the intracellu‐
lar transport of endogenous compounds, metabolizes various electrophilic xenobiotics, li‐
gand transport and thus protects cells against toxic effects [31], [87], [85]. GST catalyzes the
conjugation of glutathione on the sulfur atom of cysteine to various electrophiles and cataly‐
ses the conjugation of various electrophiles with GSH, detoxifying both exogenously and en‐
dogenously derived toxic compounds [13].
3.1. Classification and structure
The superfamily of the glutathione transferases are divided into at least four major families
of proteins, namely cytosolic or soluble GSTs, mitochondrial GSTs, microsomal GSTs and
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bacterial fosfomycin-resistance proteins [39], [6], [69]. The cytosolic GSTs (cGSTs) have been
subgrouped into numerous divergent classes on the basis of their chemical, physical and
structural properties [39], [70]. The mitochondrial GSTs, also known as kappa class GSTs,
are soluble enzymes that have been characterized in eukaryotes [65]. The third GST family
comprises membrane-bound transferases called membrane-associated proteins involved in
ecosanoid and glutathione metabolism, but these bear no similarity to soluble GSTs [44].
Representatives of all three families are also present in prokaryotes but the fourth family is
found exclusively in bacteria [4]. The mammalian soluble GSTs are so far divided into eight
classes based on their amino acid sequences including: Alpha (α), Kappa (κ), Mu (µ), Omega
(ω), Pi (π), Sigma (σ), Theta (θ) and Zeta (ζ), [11], [78], [64], [40]. GSTs are named using a
letter corresponding to their class membership and Arabic numerals after the subunit com‐
position (e.g. GST A1-1 is a homodimeric alpha class GST consisting of two subunit 1).
3.2. Presence of GST in cells
3.2.1. Microbial GST
For a long time, GST enzymes from microbial sources were neglected and were not system‐
atically studied. One of the reasons for this was the poor activity of microbial GSTs with
CDNB8 as a model substrate for GST activity, which led to the conclusion that these en‐
zymes are rare in unicellular organisms [81], [77]. The first evidence for the presence of GSTs
in bacteria was reported more 30 years ago by Takashi Shishido who showed the presence
of GST activity in a strain of Escherichia coli [71]. Since then, GSTs have been found to be
broadly distributed in aerobic prokaryotes, but not in anaerobic bacteria [59]. The absence of
the enzyme in these microorganisms is consistent with the lack of GSH [28]. Bacterial gluta‐
thione transferases are part of a superfamily of enzymes that play a key role in cellular de‐
toxification. Bacterial GSTs are implicated in a variety of distinct processes such as the
biodegradation of xenobiotics, protection against chemical and oxidative stresses and anti‐
microbial drug resistance. In addition to their role in detoxification, bacterial GSTs are also
involved in a variety of distinct metabolic processes such as the biotransformation of di‐
chloromethane, the degradation of lignin and atrazine, and the reductive dechlorination of
pentachlorophenol [4], [51].
3.2.2. GSTs of fungi and yeasts
Until recently, relatively little was known about the presence and role of GST in fungi. How‐
ever, expression of GST has been reported in some fungal species such as Issatchenkia orienta‐
lis, [73], Phanerochaete chrysosporium, Yarrowia lipolytica, Mucor circinelloides [70]
Schizosaccharomyces pombe, Aspergillus nidulans, Aspergillus parasiticus, Aspergillus flavus, As‐
pergillus fumigates [Burns et al., 2005] Saccharomyces cerevisiae, and Cunninghamella elegans,
[70] [48] etc. However, the role of the enzyme in fungi, particularly toxigenic strains, is not
well understood [2]. Although it has been shown that GST has a significant role in detoxifi‐
8 - 1-chloro-2,4-dinitrobenzene
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cation of aflatoxin and there is a possibility that this enzyme catalyses the conjugation of
GSH to AFB1- epoxide to excrete its derivatives from the body, in 1988 and for the first time
Saxena et al. reported that the relation of cytosolic GSH S-transferases from A..flavus to afla‐
toxin synthesis. In truth, they showed that in contrast to other cells that GST has a critical
function to break down the aflatoxin, in aflatoxigenic Aspergillus spp., there is positive corre‐
lation between the GST activity and aflatoxin production [68], factors influencing aflatoxin
formation such as growth period, medium etc., always enhanced GST activity in the toxi‐
genic strain. Since the non-toxigenic strain produces no aflatoxin, these factors have little ef‐
fect on its GST activity. Our experience with GSH-conjugation system using inducers/
inhibitors of aflatoxin metabolism in fungi also show a positive correlation of aflatoxin syn‐
thesis and GST activity in Aspergillus species [2], [88].
3.2.3. Plant GSTs
Plant GSTs are a family of multifunctional enzymes involved in the intracellular detoxifica‐
tion of xenobiotics and toxic compounds produced endogenously [54], [26]. Most of the en‐
zymes are stress-inducible and play a role in the protection of plants from adverse effects of
stresses. However, the activities of different GSTs have been detected and characterized in
many plants, including maize, wheat, tobacco, soybean, barley, chickpea, peanut, sorghum,
and sugarcane [20], [21], [22], [75].
3.2.4. Mammalian GST
The isoenzymes of glutathione transferase have been most widely studied in rat liver. Six
basic transferases in rat liver liver have been characterized. In rabbit, GST catalyzes the con‐
jugation of activated AFB1 with glutathione. In an experiment to assess the abilities of lung
and liver GSTs to conjugate AFB1-8, 9-epoxide, it has been shown that alpha-class and mu-
class GSTs are of similar importance in catalyzing the reaction in the lung. The human gluta‐
thione S-transferase, possess both enzymatic and non-enzymatic functions and are involved
in many important cellular processes, such as, phase II metabolism, stress response, cell pro‐
liferation, apoptosis, oncogenesis, tumor progression and drug resistance. The nonenzymat‐
ic functions of GSTs involve their interactions with cellular proteins, such as, Jun N-terminal
kinase,(JNK), tumor necrosis factor receptor-associated factor-2 (TRAF2), apoptosis-signal-
regulating kinase 1 (ASK), serine/threonine kinases (PKA, PKC), and tissue transglutami‐
nase 2 (TGM2), during which, either the interacting protein partner undergoes functional
alteration or the GST protein itself is post-translationally modified and/or functionally al‐
tered [53], [74].
3.3. Different functions of GST
3.3.1. The metabolic function of GSTs
GSTs have been reported to involve in steroid metabolism by catalyzing the isomerization of
∆5-androstene-3, 17-dione to, ∆4-androstene-3, 17-dione, and biosynthesis of prostaglandins.
GST M2-2 is a prostaglandin E synthase in the brain cortex [8] and rat GST A1-1 and GST
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A3-3 catalyze the reduction of PGH2 to PGF2. The isomerization reaction of PGF2 to PGD2 is
also catalyzed by sigma class of GST. PGD2, PGE2 and PGF2 act as hormones that bind to G-
protein coupled receptors which regulate other hormones and neurotransmittors. Prosta‐
glandin D2 and E2 are unstable and will easily be converted to prostaglandin J2 and A2,
respectively and their derivatives inhibit NFκB, [66] a family of transcription factors that
regulate the transcription of genes important for inflammatory processes. There are interest‐
ing speculations that GSTs might block other anti-inflammatory pathways by catalyzing the
conjugation of GST to PGJ2 [38], [25]
3.3.2. The ligandin function of GSTs
Because of exhibiting a ligand binding function, glutathione tranferases, have been known
as ligandin, a function, which involves the noncovalent binding of nonsubstrate hydropho‐
bic ligands such as heme, bilirubin, various steroids, and conceivably some lipophilic anti‐
cancer drugs as well. Although GSTs are generally viewed as playing a protective role in
foreign compound metabolism, they can also catalyze reactions that lead to toxification. Ex‐
amples include the GST dependent metabolism of 1,2-dibromoethane and related haloal‐
kanes and probably also metabolism of the 6-thiopurine prodrug azathioprin [60], [5].
Similarly, the cytotoxicity of the polypeptide antibiotic neocarzinostatin is greatly enhanced
by thiols such as GSH, although in this case there is no apparent requirement for GST cataly‐
sis [25], [18]. [82].
3.3.3. The regulatory function of GSTs
In addition to above functions, GSTs also are responsible for interacting the proteins and en‐
zymes. For example GST P1-1 interacts with c-Jun N-terminal kinase 1 (JNK1) suppressing the
basal kinase activity. GST P1-1 also has a role in protection and cell survival after exposure to
H2O2 but not against UV-induced apoptosis [1]. Whereas, mouse GST M1-1 protects cells
against both UV-and H2O2-induced cell death and binds to apoptosis signal-regulating kinase 1
(ASK1), inhibits its kinase activity [16]. Moreover, mouse GST A4-4 has also been proposed to in‐
teract with JNK and prevent cells from 4-hydroxynonenal induced apoptosis [15], [25].
3.3.4. The detoxification function of GSTs
As enzymes, GSTs are involved in many different detoxification reactions. They are common‐
ly referred to as phase II enzymes. They catalyze the conjugation of GSH to a wide variety of
endogenous and exogenous electrophilic toxic compounds. The GSH conjugates are excreted
as mercapturic acids by the phase III metabolic pathway [41]. GST P1-1, GST M1-1 and GST
A1-1 have been shown to catalyze the inactivation process of α, β unsaturated carbonyls like
acrolein, (a cytotoxic compound present in tobacco smoke), propenals, (generated by oxida‐
tive damage to DNA) and alkenals, (formed by oxidative damage to lipids) [25], [70].
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3.4. GST and aflatoxin
3.4.1. Introduction
Study on GSTs of Aspergillus flavus stems from its ability to synthesize the aflatoxin. Aflatox‐
ins are one of the major causes of liver cancer in certain regions of Africa and Asia [83], [61].
These secondary metabolites which primarily produced by some Aspergillus spp. are ubiqui‐
tous, and under favorable conditions can grow on a wide variety of agricultural commodi‐
ties. Aflatoxins are major concern with to public health and the most important toxicological
interest in aflatoxins has concentrated on aflatoxin B1, largely due to its acute toxicity and
carcinogenicity in humans and animals. [3], [62], [88]. Genetic studies on aflatoxin biosyn‐
thesis in A. flavus and A. parasiticus has been led to the cloning of 25 clustered genes within a
70 kb DNA region responsible for the enzymatic conversions in the aflatoxin biosynthetic
pathway [86].
3.4.2. Primary metabolism of aflatoxin B1
Once inside the body and for toxicity to occur, AFB1 undergoes enzymatic conversion to
electrophilic endo and exo stereoisomers of AFB1-8,9-epoxide by the action of mixed func‐
tion mono-oxygenase enzyme systems, CYPs are an intensively studied family of enzymes
with currently approximately 4,000 known members. They have been found in almost all
branches of the “tree of life”, ranging from microorganisms over plants to mammalians.
CYP enzymes are classified into families identified by a number (e.g., 1, 2, 3, and 4), subfa‐
milies identified by a letter (e.g., 2A, 2B, 2D, and 2E), and specific members identified by an‐
other number (e.g., CYP2E1 and CYP2A6) [47], [19].
In human, five CYP gene families, namely; CYP1, CYP2, CYP3, CYP4 and CYP7 are believed
to play crucial roles in hepatic as well as extra-hepatic metabolism and elimination of xeno‐
biotics [50], [58], [84]. This superfamily of hemoproteins aids in the oxidation of various sub‐
strates such as steroids, eicosanoids, pharmaceuticals, pesticides, pollutants, and
carcinogens [57]. As mentioned earlier, they bioactivate AFB1 to an electrophilic, highly reac‐
tive and unstable metabolite known as aflatoxin-8,9-epoxide, which binds to guanine resi‐
dues in nucleic acids, leading to irreversible damage in DNA and causing hepatocarcinoma
in humans, primates, and ducks [32], [84]. However, only AFB1 exo-epoxide (AFBO), binds
appreciably to DNA (Figure 2). The AFBO is highly unstable, and it reacts with cellular nu‐
cleophiles and can induce mutations by alkylating DNA, principally at the N7 position of
guanine forming the 8,9-dihydro- 8-(N7-guanyl)-9-hydroxy-AFB1. In addition, AFBO can
bind to proteins and other critical cellular nucleophiles [43], [63]. Initial studies reported that
concentrations of AFB1 which are likely to be achieved in the liver following ingestion of
‘‘real-world” concentrations of AFB1 are bioactivated to AFBO primarily by CYP1A2, where‐
as much higher concentrations are catalyzed by CYP3A4 [30], [46], [79]. A recent study dem‐
onstrated a dominant contribution of CYP3A4 homologues in AFBO production. AFB1
metabolism studies in human liver microsomal preparations indicate a predominant role for
CYP3A4 and that its expression level was an important determinant of the AFB1 disposition
in human liver [45]. Specific CYP3A4 inhibitors like troleandomycin have been shown to in‐
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hibit AFBO production [29], while inducers of CYP3A4 activity such as 3-methylcholan‐
threne and rifampicin, increase AFB1 metabolism in cultured human hepatocytes [49].
CYP1A homologues also metabolize AFB1 to produce the detoxified metabolite AFM1,
whereas CYP3A enzymes9, produce another detoxified metabolite, aflatoxin Q1 (AFQ1), the
major metabolite of AFB1 (Figure 2). [33]. Although both CYP1A and CYP3A isoforms oxi‐
dize AFB1, there are conflicting reports on their relative importance [63].
Figure 2. Bioactivation of AFB1 to exo and endo-epoxides and subsequent GST-catalyzed conjugation with GSH.
9 - P450 III AY and in the fetal liver P450 III A6
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CYPs may also catalyze demethylation to aflatoxin P (AFP1) of the parent AFB1 molecule,
resulting in products less toxic than AFB1. Other major metabolites in the human include
aflatoxicol (AFL), AFLH1, AFB2á and AFB1-2, 2-dihydrodiol [80].
3.4.3. Secondary metabolism of aflatoxin B1
Oxidative metabolism of AFB1 by cytochrome P450 results in the formation of several prod‐
ucts such as AFB1-epoxide which serve as substrates for phase II detoxification enzymes.
Phase II enzymes such as GSTP1 and GSTA1, found in several mammalian species and non-
tumorous liver tissues [14] are the first step in the mercapturic acid pathway, which leads to
the excretion of the xenobiotics. Because conjugation of the electrophilic AFB1-8,9-epoxide
with GSH is an alternative fate to binding to nucleophilic centers in cellular macromole‐
cules, GSTs play a critical role in the protection of tissues from the deleterious effects of bio‐
activated AFB1, and tissues vary considerably in both GST concentration and distribution of
specific GST isoforms. Two stereoisomers of AFB1-8,9-epoxide were identified: AFB1 exo-ep‐
oxide and AFB1 endo-epoxide, and their corresponding GSH conjugates; AFB1 exo-epoxide-
GSH and AFB1 endo-epoxide-GSH. It has been reported that only the exo-epoxide
effectively interacts with DNA and was at least 500-fold more potent as a mutagen than the
endo stereoisomer. [43], [72].
Throughout the animal kingdom, significant variations exist in the susceptibility of different
species to AFB1. Man and rats are sensitive to AFB1 but mice can tolerate this mycotoxin.
[35]. In man and rat as well as many mammalian species, AFB1-8,9-epoxide is efficiently con‐
jugated with reduced glutathione. Little is known about the identity of the GST which is re‐
sponsible for detoxifying activated AFB1. To date, the catalytic conjugation of AFB1-8,9-
epoxide has only been reported using rat and mouse GST as enzyme source and the ability
of GST in other species to catalyze this reaction has not been described. In the investigation
on hepatic rat GST responsible for catalyzing the conjugation of AFB1-8,9-epoxide with GSH,
it has been shown that the alpha class but not mu-class of GST possess greatest ability to
metabolize activated AFB1. Although the rat pi-class GST cannot catalyze this reaction it
might be expected that the theta-class enzyme GST is active towards AFB1-8,9-epoxide. By
contrast with the rat, the mouse exhibits high constitutive levels of GST activity towards
AFB1-8,9-epoxide and alpha-class GST in Swiss-Webster mice possess high activity towards
AFB1-8,9-epoxide and can protect against DNA-binding by AFB1 metabolites. Neither the
murine mu-class nor pi-class GST can detoxify activated AFB1 and all the activity towards
this substrate is contributed by the alpha-class GST. It can be concluded that in the mouse
the theta-class enzymes do not play a major role in the detoxification of activated AFB1.
Hamster liver contains significant levels of AFB1-GSH-conjugating activity but the GST in‐
volved have not been characterized. In human liver, GST does not appear to play as impor‐
tant a role in providing protection against AFB1 as the rodent GST. The in vitro studies have
suggested that in comparison with rodents, relatively little AFB1-GSH conjugate is pro‐
duced by human liver, but insufficient data exist to be certain that this reaction is not of
physiological importance in man, particularly as an aflatoxin mercapturate has been detect‐
ed in the urine of marmoset monkeys treated with AFB1. The ability of human alpha-class
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GST to detoxify activated AFB1 has not been examined systematically. Three separate alpha-
class isoenzymes, which represent the dimeric combinations of two distinct subunits (B1 &
B2) have been described in human liver. Furthermore, it is not known whether man possess‐
es inducible GST and if so, whether these might be involved in AFB1 metabolism [34]. Nev‐
ertheless, it has been shown that in the humans, the GST with the highest activity toward
AFB1 exo-epoxide is the polymorphic hGSTM1-1 which is absent in about 50% of individu‐
als in most human populations. This suggests that AFB1-epoxide individuals lacking the
beneficial effects of hGSTM1-1 may be at elevated risk. Indeed some reports suggest that the
GSTM1 genetic polymorphism may affect AFB1 detoxification in human liver. In contrast to
the liver, the lung is composed of many different cell types and expression of GSTs in differ‐
ent human lung cell types is heterogenous. Thus certain cell types with low levels of GSTs or
lacking specific GST isoforms may be at higher risk of AFB1 toxicity [72]. GSTP was also
demonstrated to significantly increase in early hepatocarcinogenesis and hepatocellular car‐
cinoma compared to their adjacent normal tissues. Loss of GSTP1 has been suggested to in‐
crease the risk of DNA damage and mutation. Moreover, up-expression of GSTA was
suggested to protect liver cells against oxidative stress via an extracellular signal-regulated
kinases (ERKs) and p38 kinase (p38K)-related pathway, as well as through the inhibition of
H2O2-induced apoptosis to inhibit reactive oxygen species (ROS)- induced lipid peroxida‐
tion. It was suggested that inactivated or down-regulated GSTP1 and GSTA1 genes could
increase genomic damage when individuals were exposed to carcinogens. [14]. GSTs have
also been shown to exhibit GSH-dependent peroxidase activity and thus may be involved in
resistance to oxidative stress. Cytosolic GSTs have been identified in almost all organisms,
with mammalian GSTs the most clearly characterized [Burns et al. 2005].
Besides the formation of GSH conjugates, glucuronide and sulfate conjugates of AFB1 have al‐
so been described in a variety of species including rat, mouse, monkey and trout. The ability to
form these alternative secondary metabolites may be of considerable physiological impor‐
tance in species, like the trout, that are unable to produce AFB1-GSH conjugates. Before AFB1
can form glucuronide and sulfate conjugates it requires to be hydroxylated. The primary me‐
tabolites AFM1, AFP1, and AFQ1 can readily form glucuronide or sulfate conjugates. Whilst
such conjugation reactions may aid excretion of aflatoxin, their toxicological value is unclear as
such hydroxylated metabolites are not particularly harmful because they are not subject to 8,9-
epoxidation. However, it has been proposed that AFB1 is itself capable of forming glucuronide
and sulfate conjugate; these reactions might entail a molecular rearrangement possibly involv‐
ing the addition of water to the keto group in the cyclopentone ring, that result in the introduc‐
tion of a hydroxyl group into the AFB1 structure. This proposal is of particular interest as it
enables the direct detoxification of AFB1 through reactions that may not involve cytochrome
P450. These workers have also proposed that amines, thiols and alcohols might also be conju‐
gated to AFB1 via the keto group in the cyclopentone ring [34].
Alternatively, the AFB1-epoxide can hydrolyse spontaneously to AFB1-dihydrodiol. This is
not a true detoxification process as the dihydrodiol product can rearrange at neutral pH val‐
ues to form a dialdehydic phenolate ion. This AFB1-dialdehyde can undergo Schiff-base for‐
mation with primary amine groups in proteins and is therefore likely to be cytotoxic.
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Recently, a novel AFB1-aldehyde reductase (AFB1-AR) purified from ethoxyquin (EQ)-treat‐
ed rat liver has been shown to metabolize the dialdehyde form of AFB1-dihydrodiol to an
AFB1-dialcohol and its relative importance in AFB1 detoxification may be considerable [35].
The toxicity of AFB1 is selective towards certain species. In contrast with the mouse and
hamster, the rat, guinea pig and man are susceptible to the hepatotoxic effects of AFB1 [34].
The toxicity of the mycotoxin is based on a balance between the rate of primary activation of
AFB1 and the rate of detoxification of primary metabolites or repair of cellular damage, de‐
termined by the relative activity of enzymes responsible for these reactions; the differential
toxicity of AFB1, between species is thought to be due mainly to different levels of activity of
xenobiotic-metabolizing enzymes. In this regard, the livers of mice which are resistant to the
hepatoxic effects of AFB1 contain high concentrations of a Yc-type GST subunit [55] that has
considerable GSH conjugating activity towards AFB1-epoxide [34], [37], [10], [9]. By contrast,
the Fischer rat, an inbred strain that is five times more susceptible to AFB1- induced liver
cancer than the Wistar rat [34], possesses 20-fold less hepatic AFB1-GSH-conjugating activity
than the mouse. Fischer rats can, however, be protected against AFB1 by treatment with the
antioxidant EQ. It has shown that following EQ-treatment the livers of Fischer rats express a
GST subunit that is immunochemically related to the mouse Yc subunit [35]. Moreover, this
inducible polypeptide (Yc2, subunit 10) has high activity towards AFB1-epoxide [35]. Thus,
the Yc2 subunit is thought to confer protection against AFB1, and its induction by EQ is like‐
ly to be one of the key mechanisms for the protective action of this anti-carcinogen [56].
The transport of foreign compounds out of cells can be achieved by at least two distinct fam‐
ilies of efflux pump, both of which may provide protection against AFB1 by helping elimi‐
nate the mycotoxin from target cells. The best characterized of these two pumps is P-
glycoprotein, the product of the mdr 1 gene which has been studied extensively because of
its involvement in acquired resistance to anticancer drugs. The other pump is the gluta‐
thione S-conjugate carrier which is responsible for the transport of endogenous compounds
such as oxidized glutathione and leukotriene C4 as well as glutathione conjugates of foreign
compounds an example of which might be S-(2,4-dinitrophenyl)glutathione. Both pump sys‐
tems are ATP-dependent and are inhibited by vanadate but differ in that P-glycoprotein ap‐
pears to have specificity towards hydrophobic compounds whereas the glutathione S-
conjugate carrier is as its name suggests specific for leukotrienes and drug-glutathione
conjugates. Although it is not known whether P-glycoprotein is able to transport AFB1 the
broad specificity of this efflux pump and its activity towards hydrophobic drugs suggests
that this is likely. It also appears highly probable that the glutathione S-conjugate carrier is
responsible for the transport of AFB1 conjugated with GSH. Both P-glycoprotein and the
glutathione S-conjugate carrier are expressed in the liver which is compatible with the hy‐
pothesis that these pumps could be involved in the efflux of AFB1 and its metabolites. The
involvement of P-glycoprotein in AFB1 transport is supported by the fact that aflatoxin has
been shown to induce mRNA encoding this protein in mouse liver. [36].
Relatively little is known about the enzymes responsible for the removal of AFB1 that is
bound covalently to DNA in mammalian cells. Exposure of cells to AFB1 results in the for‐
mation of three major adducts. Of these, trans-2,3-dihydro-2-(N7-guanyl)-3-hydroxy AFB1
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(AFB1- N7 G) is the most abundant. It is chemically unstable and is lost spontaneously from
DNA in vitro to yield apurinic sites. The other two adducts, 2,3-dihydro-2-(N-formyl-2,3,6-
triamino-4-oxopyrimidine-N-yl)-3-hydroxy AFB1 and 8,9-dihydro-8-(2-amino-6-forma‐
mide-4-oxo-3,4-dihydropyrimid-5-yl formamido)-9-hydroxy AFB1 (AFB1-FAPY and AFB1III
respectively) are not spontaneously but appear to be removed catalytically by DNA repair
enzymes. The loss of AFB1-DNA adducts in vivo is biphasic and this occurs through two dis‐
tinct mechanisms. Following exposure to AFB1, all adduct species are removed rapidly until
less than 1000 adducts per cell remain. Once this point is reached the AFB1-FAPY and AFB1
III adducts are no longer removed and only AFB1-N7 G is lost but at a much slower rate
from the cell [36].
3.4.4. Conclusion and future directions
Evidences presented in this review article clearly show that glutathione conjugation to afla‐
toxin metabolites which has been detected in aflatoxin-producing fungi as well as liver tis‐
sues of mammalians play a crucial role in reducing the interaction of aflatoxins with cellular
macromolecules. However further studies is needed to answer the main questions about the
contribution of glutathione conjugation system in removing aflatoxin in different cellular
systems. The future direction of this topic is to find out experimental-based answers to the
following questions:
1. What is the relationship between the rate of aflatoxin metabolism and the level of afla‐
toxin-GSH conjugate formation?
2. Which classes of glutathione S-transferases in each cellular system is directly responsi‐
ble for involvement of aflatoxin-GSH conjugate formation
3. What is the relationship between the efficiency of glutathione conjugation system and
toxic action of aflatoxins in different cell systems.
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